"Spagnuolo’s research is published today in Cancer Research, a top-ten oncology journal. Through partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) he has also filed a patent application for the use of the compound, named avocatin B, to treat AML.
“‘It’s an exciting time for our lab. With the help of CCRM we are now pursuing commercial partnership that would take avocatin B into clinical trials,’ said Spagnuolo. ‘Not only does avocatin B eliminate the source of AML, but its targeted, selective effects make it less toxic to the body, too.’”
“Avocados May Be Key to Beating Leukemia”
http://www.laboratoryequipment.com/news/2015/06/avocados-may-be-key-beating-leukemia